Register Cart 0

Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back Subscribe

Editorial (Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value)

Author(s): Vural Ozdemir, Jean Armengaud, Laurette Dube, Ramy Karam Aziz and Bartha M. Knoppers

Volume 8, Issue 4, 2010

Page: [240 - 244] Pages: 5

DOI: 10.2174/187569210793368230

Keywords: Biomarkers, biotechnology foresight, gene-centric human proteome project, nutriproteomics, personalized nutrition, population biobanks, prospective policy, proteogenomics, metabolome, Health technology assessment (HTA), Human Proteome Project (HPP), Human Genome Project (HGP), Human Proteome Organization (HUPO), mass spectrometry, Brain-to-Society (BtS), nanotechnology, biotechnology, Low and middle-income countries

Next »

Rights & Permissions Print Cite

Article Metrics

20

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Gene Delivery for Periodontal Tissue Engineering: Current Knowledge – Future Possibilities
Current Gene Therapy

Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Current Pharmaceutical Design

Experience with Androgen Deprivation Therapy for Prostate Cancer in Japan and Future Perspectives
Current Cancer Drug Targets

Growth Suppression and Mitotic Defect Induced by JNJ-7706621, an Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases
Current Cancer Drug Targets

Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma
Current Cancer Therapy Reviews

Galvez-Markov Network Transferability Indices: Review of Classic Theory and New Model for Perturbations in Metabolic Reactions
Current Drug Metabolism

Proteomics in Computer-Aided Drug Design
Current Computer-Aided Drug Design

Editorial [Hot Topic: Role of Renin-Angiotensin System (RAS) in Cancer (Guest Editor: Hiroji Uemura)]
Current Cancer Drug Targets

Molecular Mechanisms of the Action of Myricetin in Cancer
Mini-Reviews in Medicinal Chemistry

Recent Developments in the Applications of Palladium Complexes Bearing N-Heterocyclic Carbene Ligands
Current Organic Chemistry

Editorial [ Hot Topic: Novel Medicinal Chemistry Approaches to New Anti-cancer Agents (Guest Editor: Diane H. Boschelli) ]
Current Topics in Medicinal Chemistry

Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Current Pharmaceutical Design

Pinocembrin-Enriched Fractions of Elytranthe parasitica (L.) Danser Modulates Apoptotic and MAPK Cellular Signaling in HepG2 Cells
Anti-Cancer Agents in Medicinal Chemistry

Acknowledgements to Reviewers
Current Cancer Drug Targets

Nanocrystals: From Raw Material to the Final Formulated Oral Dosage Form - A Review
Current Pharmaceutical Design

Alternative Spliced Variants as Biomarkers of Colorectal Cancer
Current Drug Metabolism

BRAF as a Target for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry

Commonalities and Differences Between Crohns Disease and Ulcerative Colitis: The Genetic Clues to their Interpretation
Inflammation & Allergy - Drug Targets (Discontinued)

Assessment of the Mitotic Spindle Assembly Checkpoint (SAC) as the Target of Anticancer Therapies
Current Cancer Drug Targets

LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
Current Drug Targets

© 2025 Bentham Science Publishers | Privacy Policy